The Sino-French Fund II of Cathay Capital Private Equity is acquiring shares in medifa healthcare group, a portfolio company of the Hohnhaus & Jansenberger Group. With this investment, Cathay Capital will actively support the further growth of the company, in particular its expansion and acquisition objectives. A Milbank team led by partner Martin Erhardt advised Hohnhaus & Jansenberger comprehensively on this transaction.
The Hohnhaus & Jansenberger Group, headquartered in Munich, is a medium-sized industrial group focusing on the areas of catering equipment, medical technology and stainless steel processing. With twelve locations in the DACH region and around 600 employees, the group generates an annual turnover of around €100 million.
The medifa healthcare Group is an owner-managed and globally active medical technology company with around 350 employees. The product and service portfolio covers the complete range of modular wall, door and ceiling systems, mobile operating tables and accessories, as well as examination chairs for gynaecology, urology and proctology. The group also owns one of the largest German OEM suppliers in the medical technology sector.
Cathay Capital Private Equity is an international private equity firm focused on cross-border investments and international expansion support for mid-sized companies in North America, China and Europe. Cathay, with offices in New York, Shanghai, Beijing, Paris, Munich, San Francisco and Tel Aviv, manages assets with a total volume of more than €2.8 billion and has completed over 100 buyouts and growth capital investments since its inception in 2007. The company invests primarily in companies in the area of consumer goods and services, healthcare, business services and technology.
Advisor to Hohnhaus & Jansenberger: Milbank LLP
Martin Erhardt (lead, Corporate/M&A, Munich), Thomas Kleinheisterkamp (Tax, Munich), Alexander Rinne (Antitrust, Munich), Michael Pujol, Dominik Waldvogel, Lucas Kleinschmitt (all Corporate/M&A, Munich).
